Search

The first product to be developed will be a point-of-care rapid diagnostic test to identify pigs who have been exposed to the African Swine Fever Virus (ASFV)

This round completes an initial seed round of €2.7 million ($3.1M) brought by Invivo and CDTI-Innvierte in December 2019 and in June 2020 respectively. The total funds raised by Arthex since inception

A biotechnology startup that develops and produces viral vectors to be applied in gene therapy

Vaxdyn’s new vaccine against Gram-negative pathogens, if approved, would help curb the rising threat of drug resistant bacteria

Studies have shown that the CECT5713 strain of Lactobacillus Salivarius allowed pregnancies to be 66% effective in women with infertility of unknown cause

The Barcelona Science Park kicks off the 17th Batx2Lab, a pioneering programme which has inspired the STEM talent of more than 700 young people

VIVEbiotech, S.L. announces a collaboration with Xyphos Biosciences for the development its CAR-T™ cell therapy for people with hematological cancer.

Asebio has brought together 60 investors interested in Spanish biotech projects from 9 countries. More than five-hundred opportunities for companies participating in partnering meetings

Given the situation caused by the Covid-19 pandemic, with the recommendations of healthcare authorities in mind and foreseeing the situations that may arise over the remainder of 2020, AseBio decided